DCI Advisors Limited Filing of Claim Form

RNS Number : 1090T

DCI Advisors Limited

19 June 2024

 

DCI Advisors Limited

(the "Company" or "DCI"))

 

 

Filing of Claim Form

19 June 2024

 

The board of the Company has received notification that Miltos Kambourides and Michael Tsirikos have filed a counterclaim against the Company in the Greek Court. The Company believes the Counterclaim to be a response to the Company's criminal and civil claims against these and seven other people. The Company considers these claims to be opportunistic and without merit and will be defending them vigorously.

 

We also would like to use this opportunity to update shareholders about our recent legal win in Greece. DCP's close business partner Zoniro last year started legal proceedings against one of DCI's subsidiaries in Greece. The outcome of this legal proceeding was concluded in favour of DCI. As a result close to €500k in cash will be freed up over time for DCI's operations in Greece. We believe this judgement makes clear that the Greek legal system understands the nature of the dispute and its extent and gravity.

 

Enquiries

DCI Advisors Ltd Nicolai Huls / Nick Paris, Managing Directors	[e-mail] [phone]
Cavendish Capital Markets (Nominated Adviser & Broker) James King / Jonny Franklin‐Adams / Edward Whiley / Oscar Valeur‐Adu (Corporate Finance) Pauline Tribe (Sales)	[phone]
FIM Capital Limited (Administrator) Lesley Lennon / Grainne Devlin (Corporate Governance)	[e-mail] / [e-mail]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCBSGDLUUBDGSC